Patrick Wareing
LightNews LightNews
patrickwareing.bsky.social
Patrick Wareing
@patrickwareing.bsky.social
84 followers 490 following 260 posts
Weekly news to your inbox every Monday morning 👉https://patrickwareing.kit.com/a70ed18837
Posts Replies Media Videos
Pinned
patrickwareing.bsky.social
Patrick Wareing @patrickwareing.bsky.social · Jul 24
Too much news? Not enough time?

Stay up to date with the latest B2B life science news

patrickwareing.kit.com/email-signup
Life Science News to Your Inbox
Get a weekly summary of the past week's life science, pharma and biotech news
patrickwareing.kit.com
patrickwareing.bsky.social
Celltrion Secures $350 Million Antibody Deal Option, Expanding Beyond Biosimilars into Novel Antibody Development

patrickwareing.com/news/celltri...
Celltrion Secures $350 Million Antibody Deal Option, Expanding Beyond Biosimilars into Novel Antibody Development - Patrick Wareing
South Korean biopharmaceutical giant Celltrion announced a major strategic deal with Korea-based TriOar Therapeutics, acquiring an option to license the
patrickwareing.com
November 20, 2025 at 2:30 PM
patrickwareing.bsky.social
Tempest Therapeutics Completes All-Stock Acquisition of Factor’s CAR-T Pipeline and CEO in Strategic Move

patrickwareing.com/news/tempest...
Tempest Therapeutics Completes All-Stock Acquisition of Factor’s CAR-T Pipeline and CEO in Strategic Move - Patrick Wareing
After a period of significant restructuring marked by layoffs, Tempest Therapeutics has turned to Factor Bioscience for a lifeline by acquiring several
patrickwareing.com
November 20, 2025 at 11:45 AM
patrickwareing.bsky.social
Solve Therapeutics Raises $120 Million to Advance Next-Gen Antibody-Drug Conjugates in Solid Tumor Trials

patrickwareing.com/news/solve-t...
Solve Therapeutics Raises $120 Million to Advance Next-Gen Antibody-Drug Conjugates in Solid Tumor Trials - Patrick Wareing
Solve Therapeutics, a San Diego-based clinical-stage biotech, announced it has raised $120 million in a heavily oversubscribed financing to push its pipeline
patrickwareing.com
November 19, 2025 at 3:30 PM
patrickwareing.bsky.social
Sofinnova Partners Closes €650 Million Fund to Propel Early-Stage Biotech and Medtech Innovation

patrickwareing.com/news/sofinno...
Sofinnova Partners Closes €650 Million Fund to Propel Early-Stage Biotech and Medtech Innovation - Patrick Wareing
Sofinnova Partners, a leading European life sciences venture capital firm with offices in Paris, London, and Milan, announced the successful close of its
patrickwareing.com
November 19, 2025 at 2:00 PM
patrickwareing.bsky.social
Sensei Biotherapeutics Halts Research, Implements Major Layoffs and Strategic Review

patrickwareing.com/news/sensei-...
Sensei Biotherapeutics Halts Research, Implements Major Layoffs and Strategic Review - Patrick Wareing
Sensei Biotherapeutics , a clinical-stage biotechnology firm focused on next-generation cancer therapeutics, announced a cessation of all research and
patrickwareing.com
November 19, 2025 at 11:45 AM
patrickwareing.bsky.social
Korro Therapeutics Cuts Workforce by 34% After RNA Editing Drug Disappoints in Key Genetic Disease Trial

patrickwareing.com/news/korro-t...
Korro Therapeutics Cuts Workforce by 34% After RNA Editing Drug Disappoints in Key Genetic Disease Trial - Patrick Wareing
Korro Therapeutics announced a major retrenchment after disappointing results in a closely watched Phase I/IIa clinical trial forced the company to abandon
patrickwareing.com
November 18, 2025 at 4:15 PM
patrickwareing.bsky.social
Repare Therapeutics to Be Acquired by XenoTherapeutics in Strategic Deal Valued at $6.17 Million

patrickwareing.com/news/repare-...
Repare Therapeutics to Be Acquired by XenoTherapeutics in Strategic Deal Valued at $6.17 Million - Patrick Wareing
Repare Therapeutics , a clinical-stage precision oncology company, has agreed to be acquired by XenoTherapeutics, a non-profit regenerative medicine
patrickwareing.com
November 18, 2025 at 2:15 PM
patrickwareing.bsky.social
Johnson & Johnson Expands Oncology Pipeline with $3.05 Billion Acquisition of Halda Therapeutics

patrickwareing.com/news/johnson...
Johnson & Johnson Expands Oncology Pipeline with $3.05 Billion Acquisition of Halda Therapeutics - Patrick Wareing
Johnson & Johnson announced a definitive agreement to acquire Halda Therapeutics, a Yale spinout specializing in the development of targeted small
patrickwareing.com
November 18, 2025 at 10:45 AM
patrickwareing.bsky.social
Biohaven’s Upsized Offering Strengthens R&D Pipeline with $200 Million Cash Infusion

patrickwareing.com/news/biohave...
Biohaven’s Upsized Offering Strengthens R&D Pipeline with $200 Million Cash Infusion - Patrick Wareing
Biohaven concluded its latest public capital raise on November 13, 2025, generating approximately $200 million in gross proceeds before fees and expenses. The
patrickwareing.com
November 17, 2025 at 4:07 PM
patrickwareing.bsky.social
FDA Approves Poherdy as First Interchangeable Biosimilar to Roche’s Perjeta for HER2-Positive Breast

patrickwareing.com/news/fda-app...
FDA Approves Poherdy as First Interchangeable Biosimilar to Roche’s Perjeta for HER2-Positive Breast - Patrick Wareing
On November 13, 2025, the U.S. Food and Drug Administration granted approval to Poherdy (pertuzumab-dpzb) as an interchangeable biosimilar to Perjeta
patrickwareing.com
November 17, 2025 at 2:06 PM
patrickwareing.bsky.social
MSD Makes $9.2 Billion Bet on Cidara to Secure Future Antiviral Flu Leadership

patrickwareing.com/news/msd-mak...
MSD Makes $9.2 Billion Bet on Cidara to Secure Future Antiviral Flu Leadership - Patrick Wareing
MSD’s recent announcement of its $9.2 billion acquisition of Cidara Therapeutics represents a high-stakes move to both secure and diversify the company’s drug
patrickwareing.com
November 17, 2025 at 10:01 AM
patrickwareing.bsky.social
European Investment Bank Allocates €200 Million to Propel Regenerative Medicine Innovation

patrickwareing.com/news/europea...
European Investment Bank Allocates €200 Million to Propel Regenerative Medicine Innovation - Patrick Wareing
The European Investment Bank’s strategic financing initiative marks a substantial boost for regenerative medicine innovators across Europe. Recent investments
patrickwareing.com
November 14, 2025 at 5:01 PM
patrickwareing.bsky.social
Global Biologics Market Poised to Reach $926.23 Billion by 2034

patrickwareing.com/news/global-...
Global Biologics Market Poised to Reach $926.23 Billion by 2034 - Patrick Wareing
The biologics sector continues to transform modern medicine by delivering highly targeted, effective therapies for complex diseases including cancer,
patrickwareing.com
November 14, 2025 at 2:30 PM
patrickwareing.bsky.social
FDA Unveils New “Plausible Mechanism” Pathway to Expedite Bespoke Therapies

patrickwareing.com/news/fda-unv...
FDA Unveils New “Plausible Mechanism” Pathway to Expedite Bespoke Therapies - Patrick Wareing
The U.S. Food and Drug Administration has unveiled a novel regulatory strategy referred to as the “plausible mechanism pathway” to enable faster approval of
patrickwareing.com
November 14, 2025 at 11:01 AM
patrickwareing.bsky.social
Moderna Cuts Costs Amid Vaccine Sales Decline, Eyes Break-Even by 2028

patrickwareing.com/news/moderna...
Moderna Cuts Costs Amid Vaccine Sales Decline, Eyes Break-Even by 2028 - Patrick Wareing
Moderna, recognized globally for the rapid development and commercialization of its mRNA COVID-19 vaccine, is confronting a new era shaped by declining
patrickwareing.com
November 13, 2025 at 4:45 PM
patrickwareing.bsky.social
Biogen Advances Lupus Pipeline with Two Late-Stage Drug Candidates

patrickwareing.com/news/biogen-...
Biogen Advances Lupus Pipeline with Two Late-Stage Drug Candidates - Patrick Wareing
Biogen’s research and development journey in lupus is making notable strides with two promising molecules in late-stage development targeting systemic lupus
patrickwareing.com
November 13, 2025 at 2:15 PM
patrickwareing.bsky.social
AstraZeneca Acquires SixPeaks Bio for $170 Million Upfront

patrickwareing.com/news/astraze...
AstraZeneca Acquires SixPeaks Bio for $170 Million Upfront - Patrick Wareing
AstraZeneca has exercised its option to purchase SixPeaks Bio, a Swiss-based obesity startup, for an upfront payment of $170 million, with the total deal
patrickwareing.com
November 13, 2025 at 10:30 AM
patrickwareing.bsky.social
Pfizer Wins $10 Billion Bidding War for Metsera as Novo Nordisk Exits

patrickwareing.com/news/pfizer-...
Pfizer Wins $10 Billion Bidding War for Metsera as Novo Nordisk Exits - Patrick Wareing
After a fierce and public bidding war, Pfizer has emerged victorious in acquiring Metsera, a biotech focused on innovative obesity treatments, for more than
patrickwareing.com
November 12, 2025 at 5:03 PM
patrickwareing.bsky.social
Ionis Pharmaceuticals Announces “Game Changing” Triglyceride-Lowering Drug with Strong Phase III Results and Plans FDA Submission

patrickwareing.com/news/ionis-p...
Ionis Pharmaceuticals Announces "Game Changing" Triglyceride-Lowering Drug with Strong Phase III Results and Plans FDA Submission - Patrick Wareing
Ionis Pharmaceuticals unveiled groundbreaking Phase III trial data for olezarsen (formerly AKCEA-APOCIII-LRx), positioning the drug as a potential game
patrickwareing.com
November 12, 2025 at 2:15 PM
patrickwareing.bsky.social
Eli Lilly Acquires Eye Gene Therapy from MeiraGTx to Treat Ultra-Rare Childhood Blindness

patrickwareing.com/news/eli-lil...
Eli Lilly Acquires Eye Gene Therapy from MeiraGTx to Treat Ultra-Rare Childhood Blindness - Patrick Wareing
Eli Lilly announced a strategic licensing agreement with MeiraGTx granting it worldwide exclusive rights to develop and commercialize AAV-AIPL1, a gene
patrickwareing.com
November 12, 2025 at 11:01 AM
patrickwareing.bsky.social
Gilead’s Trodelvy Fails to Meet Primary Endpoint in Key Phase III Breast Cancer Trial

patrickwareing.com/science-news/
Latest Pharmaceutical, Life Science & Biotechnology News
Stay updated with the latest developments in pharmaceuticals, life sciences, and biotechnology. Expert insights & news curated by Patrick Wareing.
patrickwareing.com
November 11, 2025 at 5:01 PM
patrickwareing.bsky.social
Propanc Biopharma Secures Up to $100 Million to Fund Crypto Treasury and Accelerate Cancer Therapy Pipeline

patrickwareing.com/news/propanc...
Propanc Biopharma Secures Up to $100 Million to Fund Crypto Treasury and Accelerate Cancer Therapy Pipeline - Patrick Wareing
Propanc Biopharma, an innovative Australia-based biotechnology company, announced a strategic financing agreement to secure up to $100 million in funding
patrickwareing.com
November 11, 2025 at 2:15 PM
patrickwareing.bsky.social
Iambic Therapeutics Secures Over $100 Million to Advance AI-Driven Drug Discovery and Clinical Programs

patrickwareing.com/news/iambic-...
Iambic Therapeutics Secures Over $100 Million to Advance AI-Driven Drug Discovery and Clinical Programs - Patrick Wareing
Iambic Therapeutics, a clinical-stage biotech combining artificial intelligence with drug discovery science, announced a successful oversubscribed financing
patrickwareing.com
November 11, 2025 at 11:15 AM
patrickwareing.bsky.social
Caribou Biosciences Presents Promising Early Results for ‘Off-the-Shelf’ Cancer Cell Therapy

patrickwareing.com/news/caribou...
Caribou Biosciences Presents Promising Early Results for ‘Off-the-Shelf’ Cancer Cell Therapy - Patrick Wareing
Caribou Biosciences announced encouraging early clinical data for its allogeneic “off-the-shelf” CAR-T cell therapy, vispacabtagene regedleucel (vispa-cel),
patrickwareing.com
November 10, 2025 at 5:03 PM
patrickwareing.bsky.social
Neok Bio Launches with $75 Million Series A to Develop Dual-Targeting Antibody-Drug Conjugates for Cancer

patrickwareing.com/news/neok-bi...
Neok Bio Launches with $75 Million Series A to Develop Dual-Targeting Antibody-Drug Conjugates for Cancer - Patrick Wareing
Neok Bio, a biotechnology startup based in Palo Alto, California, has officially launched with a $75 million Series A financing round, led by principal
patrickwareing.com
November 10, 2025 at 2:45 PM